4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-040664
Chief Business Officer sold 75,000 shares at $37.95 ($2,846,310)
- Chief Business Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Parrish Jay Chief Business Officer | 2020-07-01 | Option exercise | +25,925 | $1.49 | $38,499 | 248,147 | D |
| Parrish Jay Chief Business Officer | 2020-07-01 | Option exercise | +49,075 | $1.58 | $77,293 | 297,222 | D |
| Parrish Jay Chief Business Officer | 2020-07-01 | Sale | −75,000 | $37.95 | $2,846,310 | 222,222 | D |
| Derivatives | |||||||
| Parrish Jay Chief Business Officer | 2020-07-01 | Option exercise · Stock Option (Right to Buy) | −25,925 | 46,296 | D | ||
| Parrish Jay Chief Business Officer | 2020-07-01 | Option exercise · Stock Option (Right to Buy) | −49,075 | 62,035 | D | ||
| Open-market sales · 75,000 sh · avg $37.95 · $2,846,310 | |||||||
Loading xslF345X03/doc4.xml…